Recent Finacing
Recent Raise
AmacaThera develops an injectable inverse-thermogelling hydrogel platform for localized, sustained release of small molecules, biologics, lipid nanoparticles, and cells, advancing AMT-143 as a single-injection post-surgical pain therapeutic.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
